PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 77 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $421,434 | +21.4% | 39,683 | +4.3% | 0.00% | – |
| Q4 2023 | $347,269 | -12.0% | 38,036 | -0.0% | 0.00% | – |
| Q3 2023 | $394,454 | -30.2% | 38,038 | -3.6% | 0.00% | -100.0% |
| Q2 2023 | $565,125 | +375.1% | 39,464 | +136.9% | 0.00% | – |
| Q1 2023 | $118,960 | -31.4% | 16,661 | +7.9% | 0.00% | – |
| Q4 2022 | $173,292 | +44.4% | 15,445 | +42.9% | 0.00% | – |
| Q3 2022 | $120,000 | +36.4% | 10,812 | +4.8% | 0.00% | – |
| Q2 2022 | $88,000 | -67.5% | 10,321 | +22.4% | 0.00% | – |
| Q3 2021 | $271,000 | +21.0% | 8,429 | +27.7% | 0.00% | – |
| Q2 2021 | $224,000 | +10.9% | 6,599 | +23.0% | 0.00% | – |
| Q1 2021 | $202,000 | -23.5% | 5,366 | -32.3% | 0.00% | – |
| Q4 2020 | $264,000 | – | 7,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $197,258,000 | 18.19% |
| Abingworth LLP | 1,203,135 | $40,726,000 | 12.59% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $69,997,000 | 12.54% |
| Penn Mutual Asset Management | 86,940 | $2,943,000 | 3.68% |
| RA Capital Management | 3,115,008 | $105,443,000 | 1.69% |
| Greenspring Associates, LLC | 415,277 | $14,057,000 | 0.95% |
| Summit Rock Advisors, LP | 34,100 | $1,154,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 186,210 | $6,303,000 | 0.43% |
| Ikarian Capital, LLC | 100,000 | $3,386,000 | 0.27% |
| Eventide Asset Management | 600,000 | $20,310,000 | 0.27% |